2 Nov 2023
The results of the WFN 2023 Elections for Treasurer and one elected trustee were announced during the recent Council of Delegates Meeting, as well as the location for the WCN 2027.
19 Oct 2023
Africa currently experiences some of the most extreme shortages of neurologists and health care funding and some of the highest rates of disability due to neurological disorders in the world. Dr. Augustina Charway-Felli, president of the African Academy of Neurology, recently proposed a plan for addressing these disparities by emphasizing regional training to increase the number of neurologists throughout Africa and prioritizing education for primary care providers and non-specialists.
19 Oct 2023
Stroke is a leading cause of disability worldwide, and over 15 million people suffer a stroke each year—yet 80% of strokes are preventable. There are treatments that can successfully treat a stroke in progress and reduce long-term disability, but they must be given soon after the start of a stroke. Because global health care systems are drastically under-resourced, these treatments are often not available to the people who need them.
18 Oct 2023
There is a growing call to embrace patient engagement in the world of health care, and Kathy Oliver, chair of the International Brain Tumour Alliance (IBTA), is one of many patient advocates at the vanguard of this movement around the world. Patient organizations like IBTA are increasingly at the forefront of patient engagement across various health care domains, including in the design of clinical trials, drug development, health care policy, pricing and reimbursement decisions, and regulatory issues.
18 Oct 2023
Huda Zoghbi, MD, professor of molecular and human genetics, Baylor College of Medicine, has made a groundbreaking discovery in the field of neurology. Her research shows that mutations in the MECP2 gene are responsible for causing Rett syndrome, a childhood disorder that primarily affects females and is diagnosed in around 1 in 10,000 girls born each year.
17 Oct 2023
One of the central challenges of Amyotrophic Lateral Sclerosis ALS research is finding ways to slow the progression of the relentlessly degenerative brain disease. Recently, based on results of the HEALEY ALS Platform Trial, two experimental medications plan to move to phase 3 clinical trials. This means the drugs will now be tested on a larger sample population to confirm promising early results that showed they can slow the progression of ALS. Phase 3 trials are the last step before drugs are submitted for FDA approval.
17 Oct 2023
During a plenary lecture at the 26th World Congress of Neurology, Dr. Anthony Lang, professor of neurology and Jack Clark Chair for Parkinson's Disease Research, University of Toronto, revealed a groundbreaking new model for identifying and studying Parkinson’s disease. This new approach will help researchers investigate biological aspects of the disease that may be detectable many years before symptoms begin to show.
16 Oct 2023
Neurological disorders are currently the second highest cause of death and the leading cause of disability worldwide. A groundbreaking new Global Burden of Disease (GBD) study shows that the number of people living with brain disease is expected to double by 2050.
15 Oct 2023
The World Health Organization (WHO) revealed its new Intersectoral Global Action Plan (IGAP), a critical blueprint for combating neurological conditions that calls for urgent action from governments and health care organizations around the world. IGAP outlines goals to help governments and national health care organizations direct research and investment in areas with the greatest possible impact on global health.
15 Oct 2023
Type 2 diabetes has reached epidemic proportions, and diabetic peripheral neuropathy (DPN), a major diabetes complication, is now a leading cause of global disability. Eva L. Feldman, MD, PhD, James W. Albers Distinguished University Professor and Russell N. DeJong Professor of Neurology at Michigan Medicine, shined a light on the growing global burden of DPN and revealed evidence that diet and lifestyle modifications can improve diabetic neuropathy at the 26th World Congress of Neurology.
11 Oct 2023
The World Federation of Neurology (WFN) and the Canadian Neurological Society (CNS) will host the XXVI World Congress of Neurology (WCN) in Montreal, Canada, from October 15 to 19, 2023. WCN is a major, biennial conference where world-class neurologists and researchers gather to share the latest innovative research in the broad field of neurology. This year’s WCN marks the first in-person conference since the COVID-19 pandemic, with thousands of attendees from around the world convening to learn from one another’s research, exchange ideas and drive the field of neurology forward.
19 Jul 2023
This year marks the 10th Anniversary of World Brain Day and WFN is partnering with the World Federation for Neurorehabilitation (WFNR). Registration is now open for the free 2023 World Brain Day webinar.
27 May 2023
The Nominating Committee of the World Federation of Neurology now recommends to the membership candidates for WFN Treasurer and Elected Trustee.
11 Apr 2023
The World Federation of Neurology (WFN) is pleased to announce Brain Health and Disability as the theme for its 10th Annual World Brain Day (WBD) on Saturday, July 22. This year’s theme Brain Health and Disability will inspire a global initiative to close the gaps in disability awareness and reduce health care barriers that exist for individuals with neurological disabilities. When it comes to brain health, may we leave no one behind.
30 Dec 2022
On 28 December, 2023, WFN President Prof Dr Wolfgang Grisold was honoured to be invited to serve as a member of World Health Organisation's (WHO) Support Group for the "Global Road Map to Defeat Meningitis by 2030" on behalf of World Federation of Neurology (WFN).
14 Nov 2022
The World Federation of Neurology is pleased to announce the appointments of Prof Riadh Gouider and Prof Marco Tulio Medina as co-opted Trustees for a one-year term covering the period from October 2022 to the next Council of Delegates meeting in October 2023.
27 Oct 2022
The results of the WFN 2022 Elections for Secretary General and elected trustee were announced during the recent Council of Delegates Meeting.
12 Aug 2022
The WFN looks forward to hearing from any member neurological society in the African and Pan Arab regions that wish to be considered as the host of WCN 2027.
19 Jul 2022
July 22 is devoted to Brain Health for All for World Brain Day (WBD). This year, in a free webinar, the World Federation of Neurology (WFN) is featuring leading experts from regional and global organizations who are prioritizing brain health, including the World Health Organization (WHO).
27 May 2022
The adoption of IGAP results from years of work and consultations with WFN, other members of the Global Neurological Alliance, the WHO Secretariat and the Member States.